
Opinion|Videos|July 24, 2024
Future Directions in the Management of Multiple Myeloma
Author(s)Alfred L. Garfall, MD
Alfred L. Garfall, MD, discusses his hopes for the future treatment landscape of multiple myeloma.
Advertisement
Video content above is prompted by the following questions:
- Please discuss any other data in multiple myeloma released at ASCO 2024 that you find noteworthy to share with colleagues.
- Outside of ASCO 2024, what ongoing research efforts are you most excited for in the treatment and management of multiple myeloma? What can we look forward to through the end of the year and beyond?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
2
New Insight on Biologic Initiation Patterns for Treating Severe Asthma
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
Planetary Health Highlights Global Links Between Climate, Respiratory Well-Being
5